MaxCyte, Inc. (MXCT)
1.09
+0.01
(+0.93%)
USD |
NASDAQ |
Oct 06, 16:00
1.09
0.00 (0.00%)
After-Hours: 19:00
MaxCyte Cash from Investing (Quarterly) : 6.566M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.566M |
| March 31, 2026 | 2.656M |
| December 31, 2025 | 9.676M |
| September 30, 2025 | 5.192M |
| June 30, 2025 | 1.538M |
| March 31, 2025 | 9.529M |
| December 31, 2024 | -1.665M |
| September 30, 2024 | 3.608M |
| June 30, 2024 | 19.38M |
| March 31, 2024 | -14.40M |
| December 31, 2023 | -4.139M |
| Date | Value |
|---|---|
| September 30, 2023 | 2.815M |
| June 30, 2023 | 26.67M |
| March 31, 2023 | 29.64M |
| December 31, 2022 | -27.10M |
| September 30, 2022 | -60.67M |
| June 30, 2022 | -131.85M |
| March 31, 2022 | 194.80M |
| December 31, 2021 | -11.44M |
| September 30, 2021 | -162.35M |
| June 30, 2021 | -36.92M |
| March 31, 2021 | 15.69M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp. | -2.089M |
| Bio-Techne Corp. | -7.057M |
| BioLife Solutions, Inc. | -1.579M |
| MindWalk Holdings Corp. | -0.0559M |
| Maravai Lifesciences Holdings, Inc. | -0.37M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.661M |
| Cash from Financing (Quarterly) | -1.42M |
| Free Cash Flow | -23.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0442 |
| Free Cash Flow to Equity (Quarterly) | -4.487M |
| Free Cash Flow to Firm (Quarterly) | -4.723M |
| Free Cash Flow Yield | -20.45% |